中国现代医药杂志
中國現代醫藥雜誌
중국현대의약잡지
MODERN MEDICINE JOURNAL OF CHINA
2014年
3期
16-18
,共3页
辛伐他汀%激素性股骨头坏死%治疗%大鼠
辛伐他汀%激素性股骨頭壞死%治療%大鼠
신벌타정%격소성고골두배사%치료%대서
Simvastatin%Steroid-induced femoral head necrosis%Therapy%Rat
目的:研究辛伐他汀治疗大鼠早期激素性股骨头坏死的效果。方法将55只大鼠随机分成空白组(K组)15只,实验组40只,向实验组按20mg/kg剂量交替经大鼠双侧臀大肌注射地塞米松磷酸钠,每周1次,制备大鼠早期激素性股骨头缺血坏死模型。造模6周后将成功的30只大鼠随机分成造模组(Z组)和灌胃治疗组(G组),每组15只。 G组以辛伐他汀(10mg·kg-1·d-1)灌胃治疗,K、Z组以等剂量的蒸馏水灌胃。灌胃4、8、12周,取股骨,分别进行股骨头骨密度分析及股骨头大体和光镜观察。结果①G组灌胃治疗后各时间相点股骨头骨密度均有不同程度的增高,12周后骨密度水平显著高于Z组,两组比较差异有统计学意义(P<0.01);②G组灌胃治疗后股骨头的形状完整,逐显光滑,色泽逐渐接近正常,光镜下见骨小梁不同程度增粗,结构渐规则,新生毛细血管、骨组织日益明显,髓腔内脂肪细胞大小及分布均匀;③G组灌胃治疗后各时间相点空骨陷窝数均有减少,12周后空骨陷窝率明显低于Z组,两组比较差异有统计学意义(P<0.05)。结论辛伐他汀可能通过多种机制,促进早期激素性股骨头坏死的修复。
目的:研究辛伐他汀治療大鼠早期激素性股骨頭壞死的效果。方法將55隻大鼠隨機分成空白組(K組)15隻,實驗組40隻,嚮實驗組按20mg/kg劑量交替經大鼠雙側臀大肌註射地塞米鬆燐痠鈉,每週1次,製備大鼠早期激素性股骨頭缺血壞死模型。造模6週後將成功的30隻大鼠隨機分成造模組(Z組)和灌胃治療組(G組),每組15隻。 G組以辛伐他汀(10mg·kg-1·d-1)灌胃治療,K、Z組以等劑量的蒸餾水灌胃。灌胃4、8、12週,取股骨,分彆進行股骨頭骨密度分析及股骨頭大體和光鏡觀察。結果①G組灌胃治療後各時間相點股骨頭骨密度均有不同程度的增高,12週後骨密度水平顯著高于Z組,兩組比較差異有統計學意義(P<0.01);②G組灌胃治療後股骨頭的形狀完整,逐顯光滑,色澤逐漸接近正常,光鏡下見骨小樑不同程度增粗,結構漸規則,新生毛細血管、骨組織日益明顯,髓腔內脂肪細胞大小及分佈均勻;③G組灌胃治療後各時間相點空骨陷窩數均有減少,12週後空骨陷窩率明顯低于Z組,兩組比較差異有統計學意義(P<0.05)。結論辛伐他汀可能通過多種機製,促進早期激素性股骨頭壞死的脩複。
목적:연구신벌타정치료대서조기격소성고골두배사적효과。방법장55지대서수궤분성공백조(K조)15지,실험조40지,향실험조안20mg/kg제량교체경대서쌍측둔대기주사지새미송린산납,매주1차,제비대서조기격소성고골두결혈배사모형。조모6주후장성공적30지대서수궤분성조모조(Z조)화관위치료조(G조),매조15지。 G조이신벌타정(10mg·kg-1·d-1)관위치료,K、Z조이등제량적증류수관위。관위4、8、12주,취고골,분별진행고골두골밀도분석급고골두대체화광경관찰。결과①G조관위치료후각시간상점고골두골밀도균유불동정도적증고,12주후골밀도수평현저고우Z조,량조비교차이유통계학의의(P<0.01);②G조관위치료후고골두적형상완정,축현광활,색택축점접근정상,광경하견골소량불동정도증조,결구점규칙,신생모세혈관、골조직일익명현,수강내지방세포대소급분포균균;③G조관위치료후각시간상점공골함와수균유감소,12주후공골함와솔명현저우Z조,량조비교차이유통계학의의(P<0.05)。결론신벌타정가능통과다충궤제,촉진조기격소성고골두배사적수복。
Objective To research the effect of simvastatin on curing rats,femoral head necrosis due to corticosteroid in the early stage. Methods A total of 55 rats were randomly divided into normal control group (n=15) and experimental group (n=40). The experimental group was injected with dexamethasone sodium phosphate (20mg/kg) into gluteus maximus once a week to make rats,steroid-induced femoral head necrosis model in the early stage. At the sixth week, 30 out of 40 rats were e-qually divided into model group and simvastatin therapy group. The therapy group was intragastrically administrated with simvas-tatin (10mg/kg) once a day. Model and control groups were intragastrically administrated with the equal volume of saline. The femoral was obtained at 4, 8, and 12 weeks and the the femoral head was analysed with the bone mineral density and observed with general observation and light microscope. Results ①After 12 weeks of treatment, the bone mineral density in the thera-py group was significantly higher than that in the model group, the difference was statistically significant (P<0.01).②Gross ob-servation and light microscopy in therapy group demonstrated that the femoral head was in good shape ,the colour and luster of it was gradually getting normal. The bone trabecula increased thickly in many regions and the structure was nearly regular. A large quantity of newborn bone-tissue and lots of newborn microvessels could been found around the necrosis regions and the shape of marrow cavity showed almost normal appearance. ③After 12 weeks of treatment, the percentage of empty osteocyte lacunae was obviously lower in the therapy group than those in the model group,the difference was statistically significant (P<0.05). Con-clusion Simvastatin can effectively restore steroid-induced femoral head necrosis in the early stage by several ways.